Considerations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer’s disease
- DOI
- 10.3389/fneur.2026.1863897
- Published
- 2026-08-10
- Container
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fneur.2026.1863897,
title = {Considerations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer’s disease},
author = {Andrew E. Budson and Peter A. Ljubenkov and Aaron Ritter and Cara Leahy and Vijay K. Ramanan and Jared Brosch and Anna Burke and Brandy R. Matthews},
year = {2026},
journal = {Frontiers in Neurology},
doi = {10.3389/fneur.2026.1863897},
url = {https://doi.org/10.3389/fneur.2026.1863897}
}RIS
TY - JOUR TI - Considerations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer’s disease AU - Andrew E. Budson AU - Peter A. Ljubenkov AU - Aaron Ritter AU - Cara Leahy AU - Vijay K. Ramanan AU - Jared Brosch AU - Anna Burke AU - Brandy R. Matthews PY - 2026 JO - Frontiers in Neurology DO - 10.3389/fneur.2026.1863897 UR - https://doi.org/10.3389/fneur.2026.1863897 ER -
APA
Budson, A. E., Ljubenkov, P. A., Ritter, A., Leahy, C., Ramanan, V. K., Brosch, J., Burke, A., & Matthews, B. R. (2026). Considerations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer’s disease. Frontiers in Neurology. https://doi.org/10.3389/fneur.2026.1863897
Source records
- crossref · retrieved 2026-09-26T04:20:03.663Z